LISTEN TO THE COIQ PODCAST:

  • Telemedicine is here to stay. What to expect the day after w/ Joe Kvedar

How to generate sales before you even have a product w/ Richard Lin

 

 

When you’re a new-to-the-scene founder and you’re out to prove yourself, you need to be scrappy and creative. 

Success in the digital healthcare space is always difficult - finding funding and generating sales in a market with heightened volatility is nearly impossible - especially for a newcomer.

Nearly. But not quite.

Enter Richard Lin and his experience with a healthcare problem and his “gut” feeling that planted the seed of an idea that grew into his company, Thryve.

No one wants to be the company that builds a beautiful piece of tech that nobody wants to buy - and Richard shows our listeners and viewers just how to avoid that trap.

So, get ready because in our latest episode, Richard dives into topics from commercialization to funding to discovery and beyond, while putting a unique, humble and creative spin on each! 

 

Here are the show highlights:

  • This is one way to enjoy a B2C commercialization win (3:38)
  • How commercialization in the B2C space difference from B2B (5:57)
  • First time founders can try this to increase their chances with investors (7:06)
  • How VC funding has changed from then to now (9:44)
  • Try this 4-step sequence to improve your lead indicator metrics (21:12)
  • This is how you implement and improve on customer discovery (32:21)

I've spoken with dozens of health innovators, and nearly everyone is trying to figure out their best pivot strategy. But they don't know what to change, how to pivot, or if their new pivot strategy is the right move.

So I went into overdrive putting together a clear, actionable 5-step worksheet that will help you quickly define your most viable and profitable pivot path through the COVID crisis. And I’m giving it to you for FREE — no strings attached at legacy-dna.com/pivot

 

Guest Bio

Richard Lin is CEO and Co-Founder of Thryveinside,  a venture focused on microbiome genomic testing and personalized probiotic therapeutics.

Leveraging his background and education, Richard labored to develop what he terms the “23andMe for the microbiome” - a direct-to-consumer DNA solution centered on gut health.

Richard earned  his BA in Economics and Communication from the University of California, Davis. 

If you’d like more information about Thryve, or just wish to reach out to Richard, you can reach him directly at richard@thryveinside.com, follow him on LinkedIn at Richard Lin or, for more information about Thryve, you can follow them on Facebook or Twitter at @ThryveInside.